Cargando…
Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19
Patients with preexisting metabolic disorders such as diabetes are at a higher risk of developing severe coronavirus disease 2019 (COVID-19). Mitochondrion, the very organelle that controls cellular metabolism, holds the key to understanding disease progression at the cellular level. Our current stu...
Autores principales: | Wang, Ya, Schughart, Klaus, Pelaia, Tiana Maria, Chew, Tracy, Kim, Karan, Karvunidis, Thomas, Knippenberg, Ben, Teoh, Sally, Phu, Amy L., Short, Kirsty R., Iredell, Jonathan, Thevarajan, Irani, Audsley, Jennifer, Macdonald, Stephen, Burcham, Jonathon, Tang, Benjamin, McLean, Anthony, Shojaei, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917147/ https://www.ncbi.nlm.nih.gov/pubmed/36768847 http://dx.doi.org/10.3390/ijms24032524 |
Ejemplares similares
-
Blood transcriptome responses in patients correlate with severity of COVID-19 disease
por: Wang, Ya, et al.
Publicado: (2023) -
The Role of Transcriptomics in Redefining Critical Illness
por: Pelaia, Tiana M., et al.
Publicado: (2023) -
Clinical presentation and management of COVID‐19
por: Thevarajan, Irani, et al.
Publicado: (2020) -
Blood transcriptome analysis of patients with uncomplicated bacterial infection and sepsis
por: Herwanto, Velma, et al.
Publicado: (2021) -
Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol
por: Tang, Benjamin, et al.
Publicado: (2021)